RxDoctor Payments Data

Alvin Wee, MD

Urology · Indianapolis, INNPI 1558539874

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (51.0%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Veloxis Pharmaceuticals, Inc. accounts for 71.7% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2022 at $20,796 and has fallen 67.5% since, to $6,758 in 2025. Among urology clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$46,104in general payments, 2019–2025

Across 111 payments — averaging $415.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Veloxis Pharmaceuticals, Inc.$33K
  • Globus Medical$4K
  • Transmedics, Inc.$3K
  • Medtronic$2K
  • VB Spine LLC$2K
  • Dilon Technologies, Inc.$425
  • plus $2K from 15 others

What the payments were for

  • Consulting fees$23,50051%
  • Speaking & faculty fees$4,0009%
  • Travel & lodging$12,90128%
  • Food & beverage$5,70312%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$46,104 in reported general payments places this provider in the 90th percentile of 272 urology providers in Indiana.

See all urology providers in Indiana

Medicare billing

Part B allowed, 2024
$128,340
Medicare patients
124
Services billed
327

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim21$184
Amlodipine Besylate12$84
Atorvastatin Calcium12$55
Finasteride12$24

Paid to pharmacies, not to this prescriber.

Other urology in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →